N
Patient 1
THIS EVENT OCCURRED IN (B)(6). (B)(4).
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | COBAS 6000 C (501) MODULE | CLINICAL CHEMISTRY ANALYZER | ROCHE DIAGNOSTICS | CEO | C501 | 04745914001 | NA | R | Y | |||
| 1 | COBAS 6000 C (501) MODULE | CLINICAL CHEMISTRY ANALYZER | ROCHE DIAGNOSTICS | JJE | C501 | 04745914001 | NA | R | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2017-11-09 | 0 |
Patient 1
THIS EVENT OCCURRED IN (B)(6). (B)(4).
Patient 1
THE CUSTOMER STATED THAT THEY RECEIVED AN ERRONEOUS RESULT FOR ONE PATIENT SAMPLE TESTED FOR PHOS2 PHOSPHATE (INORGANIC) VER.2 - PHOS ON A COBAS 6000 C (501) MODULE - C501. THE ERRONEOUS RESULT WAS NOT REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE INITIALLY RESULTED AS 6.16 MG/DL. THE SAMPLE WAS REPEATED ON (B)(6) 2017, RESULTING AS 3.34 MG/DL. NO ADVERSE EVENTS WERE ALLEGED TO HAVE OCCURRED WITH THE PATIENT. THE PHOS REAGENT LOT NUMBER WAS 196352, WITH AN EXPIRATION DATE OF 31-JAN-2018. CALIBRATION AND QUALITY CONTROL RECOVERY WERE OK.